NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/11/2026 10:57
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6.48 mln
Float0.47 mln
Earnings Date05/01/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.03
Debt-free
ROE
-57.24
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
enVVeno Medical Corporation is a California-based company working to improve how venous disease is treated through the development of replacement venous valves. Its primary product, the VenoValve, is surgically implanted into the femoral vein to treat chronic venous insufficiency. The company is also developing the enVVe, a catheter-based valve system that offers a less invasive alternative. Founded in 1999 and formerly known as Hancock Jaffe Laboratories, enVVeno Medical is headquartered in Irvine, California.
